Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Genetic and Environmental Factors in the Response to Influenza Vaccination

Trial Profile

Genetic and Environmental Factors in the Response to Influenza Vaccination

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Aug 2018

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine live (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Acronyms SLVP028
  • Most Recent Events

    • 24 Jul 2018 Planned number of patients changed to 97.
    • 24 Jul 2018 Planned End Date changed to 1 Dec 2018.
    • 24 Jul 2018 Planned primary completion date changed to 1 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top